Ultimovacs ASA (Norway) Price History

ULTI Stock  NOK 2.22  0.07  3.26%   
If you're considering investing in Ultimovacs Stock, it is important to understand the factors that can impact its price. As of today, the current price of Ultimovacs ASA stands at 2.22, as last reported on the 31st of January, with the highest price reaching 2.28 and the lowest price hitting 2.15 during the day. Ultimovacs ASA appears to be dangerous, given 3 months investment horizon. Ultimovacs ASA owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0887, which indicates the firm had a 0.0887 % return per unit of risk over the last 3 months. By inspecting Ultimovacs ASA's technical indicators, you can evaluate if the expected return of 0.59% is justified by implied risk. Please review Ultimovacs ASA's Semi Deviation of 3.98, risk adjusted performance of 0.0741, and Coefficient Of Variation of 1276.26 to confirm if our risk estimates are consistent with your expectations.
  
Ultimovacs Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0887

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsULTI
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 6.63
  actual daily
59
59% of assets are less volatile

Expected Return

 0.59
  actual daily
11
89% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
6
94% of assets perform better
Based on monthly moving average Ultimovacs ASA is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ultimovacs ASA by adding it to a well-diversified portfolio.

Ultimovacs ASA Stock Price History Chart

There are several ways to analyze Ultimovacs Stock price data. The simplest method is using a basic Ultimovacs candlestick price chart, which shows Ultimovacs ASA price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 18, 20242.76
Lowest PriceNovember 13, 20241.7

Ultimovacs ASA January 31, 2025 Stock Price Synopsis

Various analyses of Ultimovacs ASA's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Ultimovacs Stock. It can be used to describe the percentage change in the price of Ultimovacs ASA from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Ultimovacs Stock.
Ultimovacs ASA Price Action Indicator 0.04 
Ultimovacs ASA Price Rate Of Daily Change 1.03 
Ultimovacs ASA Price Daily Balance Of Power 0.54 

Ultimovacs ASA January 31, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Ultimovacs Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Ultimovacs ASA intraday prices and daily technical indicators to check the level of noise trading in Ultimovacs Stock and then apply it to test your longer-term investment strategies against Ultimovacs.

Ultimovacs Stock Price History Data

The price series of Ultimovacs ASA for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 has a statistical range of 1.06 with a coefficient of variation of 12.68. The daily prices for the period are distributed with arithmetic mean of 2.14. The median price for the last 90 days is 2.15.
OpenHighLowCloseVolume
01/31/2025
 2.28  2.28  2.15  2.22 
01/30/2025 2.28  2.28  2.15  2.22  170,813 
01/29/2025 2.28  2.28  2.13  2.15  103,182 
01/28/2025 2.20  2.29  2.15  2.20  134,086 
01/27/2025 2.15  2.19  2.14  2.16  120,366 
01/24/2025 2.15  2.22  2.12  2.17  193,948 
01/23/2025 2.14  2.19  2.12  2.15  127,415 
01/22/2025 2.10  2.17  2.10  2.13  168,750 
01/21/2025 2.10  2.17  2.10  2.12  108,079 
01/20/2025 2.11  2.17  2.09  2.16  250,819 
01/17/2025 2.09  2.14  2.07  2.14  63,755 
01/16/2025 2.10  2.17  2.10  2.10  146,446 
01/15/2025 2.07  2.17  2.02  2.17  255,625 
01/14/2025 2.08  2.18  2.08  2.12  380,478 
01/13/2025 2.20  2.20  2.05  2.08  283,192 
01/10/2025 2.35  2.35  2.17  2.17  607,537 
01/09/2025 2.40  2.44  2.24  2.25  856,727 
01/08/2025 2.44  2.45  2.37  2.42  444,174 
01/07/2025 2.42  2.44  2.38  2.40  357,972 
01/06/2025 2.44  2.50  2.40  2.49  281,205 
01/03/2025 2.44  2.44  2.40  2.44  164,798 
01/02/2025 2.36  2.46  2.35  2.46  339,682 
12/30/2024 2.42  2.49  2.33  2.33  489,783 
12/27/2024 2.43  2.49  2.42  2.42  366,504 
12/23/2024 2.55  2.59  2.40  2.44  1,027,558 
12/20/2024 2.63  2.70  2.53  2.55  549,582 
12/19/2024 2.68  2.76  2.60  2.65  832,124 
12/18/2024 2.80  3.29  2.73  2.76  3,969,664 
12/17/2024 2.40  2.49  2.33  2.40  209,383 
12/16/2024 2.54  2.55  2.38  2.44  524,740 
12/13/2024 2.40  2.58  2.40  2.55  439,075 
12/12/2024 2.44  2.60  2.36  2.39  391,207 
12/11/2024 2.65  2.68  2.40  2.42  597,719 
12/10/2024 2.47  2.84  2.40  2.55  959,471 
12/09/2024 2.35  2.50  2.30  2.47  771,432 
12/06/2024 2.30  2.36  2.19  2.25  368,113 
12/05/2024 2.05  2.34  2.05  2.17  344,161 
12/04/2024 2.10  2.23  2.00  2.13  743,118 
12/03/2024 1.92  2.09  1.90  2.01  351,863 
12/02/2024 2.04  2.04  1.90  1.93  391,238 
11/29/2024 1.98  2.18  1.98  1.98  550,813 
11/28/2024 2.01  2.19  1.95  2.03  278,112 
11/27/2024 2.02  2.11  2.02  2.04  143,298 
11/26/2024 2.04  2.19  2.04  2.07  440,431 
11/25/2024 2.13  2.15  1.98  2.05  753,710 
11/22/2024 2.30  2.33  2.11  2.16  403,710 
11/21/2024 2.24  2.50  2.13  2.27  621,266 
11/20/2024 2.05  2.40  2.05  2.20  600,804 
11/19/2024 2.35  2.50  2.05  2.07  667,733 
11/18/2024 1.71  2.40  1.71  2.40  1,418,146 
11/15/2024 1.75  1.78  1.71  1.75  190,879 
11/14/2024 1.70  1.79  1.70  1.74  157,316 
11/13/2024 1.80  1.80  1.70  1.70  125,020 
11/12/2024 1.85  1.85  1.77  1.80  154,838 
11/11/2024 1.73  1.84  1.73  1.81  57,345 
11/08/2024 1.80  1.87  1.71  1.73  51,715 
11/07/2024 2.00  2.00  1.77  1.85  167,101 
11/06/2024 1.80  2.00  1.75  1.85  579,840 
11/05/2024 1.85  1.85  1.73  1.73  104,805 
11/04/2024 1.84  1.84  1.76  1.76  213,796 
11/01/2024 1.87  1.87  1.70  1.75  121,043 

About Ultimovacs ASA Stock history

Ultimovacs ASA investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ultimovacs is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ultimovacs ASA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ultimovacs ASA stock prices may prove useful in developing a viable investing in Ultimovacs ASA
Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for various cancers. The company was incorporated in 2011 and is headquartered in Oslo, Norway. ULTIMOVACS ASA is traded on Oslo Stock Exchange in Norway.

Ultimovacs ASA Stock Technical Analysis

Ultimovacs ASA technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Ultimovacs ASA technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Ultimovacs ASA trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

Ultimovacs ASA Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Ultimovacs ASA's price direction in advance. Along with the technical and fundamental analysis of Ultimovacs Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ultimovacs to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Other Information on Investing in Ultimovacs Stock

Ultimovacs ASA financial ratios help investors to determine whether Ultimovacs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ultimovacs with respect to the benefits of owning Ultimovacs ASA security.